Veyong Ya Ci Gaba da Binciken EDQM na EU

A ranar 22 ga Afrilu, labari mai daɗi ya zo!Hebei Veyong Pharmaceutical Co., Ltd. ya sake samun nasarar samun takardar shedar CEP ta EUivermectinAPI ɗin da Hukumar Kula da Ingantattun Magunguna ta Turai (EDQM) ta bayar.

IvermectinAPI shine ɗayan manyan samfuran Veyong Pharma.Abokan ciniki suna karɓa sosai a gida da waje saboda ƙarfin kwanciyar hankali, inganci mai kyau da tsarin samar da kore.A cikin 2018, ta sami nasarar samun takardar shedar FDA ta Amurka.

Takaddun shaida na ivermectin CEP ita ce takardar shaidar daidaitawa ta Pharmacopoeia ta Turai, wacce ba dukkanin ƙasashe membobin EU ba ne kawai suka amince da ita ba, har ma da ƙasashe da yawa waɗanda suka amince da matsayin Turai Pharmacopoeia.Samun takardar shedar CEP kuma shine amincewa da samfuran Veyong Pharma a kasuwannin duniya, siffar gasa ta kasuwar Veyong, da kuma wata muhimmiyar alama ta samun ci gaban kasuwanci mai inganci a kasuwannin ketare.